Form 4: Sagimet Biosciences Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Elizabeth Rozek, General Counsel and CCO of Sagimet Biosciences Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On July 19, 2024, Elizabeth Rozek, the General Counsel and CCO of Sagimet Biosciences Inc., sold 10,914 shares of Series A Common Stock.
- The sale was executed at a price of $3.0997 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Rozek directly owns 160,506 shares of Sagimet Biosciences Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives.
Stakeholder Impact
- The sale has a minimal impact on stakeholders as it is a routine transaction to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/19/2024 | Date of the stock sale transaction. |
| 07/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.